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Summary: Specific binding of [I25I]insulin to isolated erythrocytes was investigated in four groups of children
(A) Healthy children under 10 years of age (n = 20)
(B) Healthy children over 10 years of age (n = 13)
(C) Diabetic children under 10 years of age (n = 12)
(P) Diabetic children over 10 years of age (n = 63)
In addition, all diabetic children (n = 75) were subdivided into four groups according to the duration of dia-
betes
(E) <2 years, (F) 2-4 years, (G) 4-6 years, and (H) >6 years
By means of a nonlinear regression analysis for the extraction of binding parameters (assuming a single
receptor class model with independent receptor sites) and methods of variance analysis, statistically significant
differences were observed for the receptor affinities Ka (lO8 1/mol) and the receptor concentrations X0
(nmol/ ) between groups A and C, B and D, C and D, but not between A and B. The affinities of groups C and
D were foüiid to be higher than the coiresponding values of groups A and B, whereas the receptor concentra-
tions exhibited an inverse behaviour.
A significant increase of the receptor concentration and decrease of the receptor affinity depending on the
duration of diabetes could only be iproved to exist during the first 2 years of the disease.
Insulinbindung an Erythrocyten bei Kindern mit Typ-l-Diabetes
Zusammenfassung: Die Bindung von [1?5I]Insulin an Erythrocyten wurde bei vier Gruppen untersucht:
(A) Gesunde Kinder jünger als 10 Jahre (n = 20)
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(B) Gesunde Kinder älter als 10 Jahre (n = 13)
(C) Diabetische Kinder jünger als 10 Jahre (n = 12)
(D) Diabetische Kinder älter als 10 Jahre (n = 63)
Zusätzlich wurden die diabetischen Kinder (n = 75) entsprechend ihrer Diabetesdauer in vier weitere Grup-
pen unterteilt:
(E) <2 Jahre, (F) 2-4Jahre, (G) 4-6 Jahre und (H) >6 Jahre
Mit Hilfe einer nichtlinearen Regressionsanalyse zur Ermittlung der Bindungskenngrößen für ein einklassiges
Rezeptormodell mit unabhängigen Bindungsstellen und Varianzanalyse wird gezeigt, daß statistisch signifi-
kante Unterschiede zwischen den Rezeptorkonzentrationen XQ (nmöl/1) sowie den Rezeptoraffinitäten Ka
(108 1/mol) der Gruppen A und C, B und D, C.und D, jedoch nicht A und B bestehen. Hierbei sind die
Rezeptoraffinitäten der Gruppen C und D größer als diejenigen der Gruppen A und B, während die Reze,r>
torkonzentrationen das entgegengesetzte Verhalten zeigen.
Eine signifikante Änderung der Rezeptorkonzentrationen und Rezeptoraffinitäten in Abhängigkeit von der
Diabetesdauer konnte nur innerhalb der ersten 2 Erkrankungsjahre nachgewiesen werden. ·
Introduction
Many disorders oNf glucose homeostasis are charac-
terized by an altered insulin binding to target and
non-target cells (1—3).
Children with type-I diabetes, on the other hand,
have not been sufficiently studied with respect to
their insulin binding (4—6).
This gap is primarily due to the excessive amount of
blood required for complete binding studies on cir-
culating leukocytes or monocytes (4, 6, 7). Recent
reports have described insulin receptors on human
erythrocytes and have led to the conclusion that ery-
throcytes can partially be considered äs representa-
tive of insulin receptors on the cells of other body
tissues (8-10).
As complete insulin binding studies on erythrocytes
can be carried out with less than 10 ml of whole
blood, this method is especially helpful in studies of
insulin receptors in children (11).
Though some reports of insulin receptors on ery-
throcytes in children with type-I diabetes have been
published (4, 5, 11, 12), sufficient data with regard
to the influence of age and duration of diabetes on
the insulin binding on erythrocytes are still lacking.
Materials and Methods
Subjeas
In 75 ambulatory-treated children (d 28, 9 47) aged between 4
and 18 years (x ± s, 13.28 ± 3.65 years) with type-I diabetes the
insulin binding to erythrocytes was measured. The duration of di-
abetes was between one month and fifteen years ( ± s, 4.88 ±
2.97 years); the mean age of diabetes manifestation was 8.1 years.
Four groups of children were investigated
(A) Healthy children under 10 years of age (n = 20)
(B) Healthy children over 10 years of age (n = 13)
(C) Diabetic children under 10 years of age (n ^ 12)
(P) Diabetic children over 10 years of age (n = 63)
In addition, all diabetic children (n = 7-5) were subdivided into
four groups according to the duration of diabetes
(E) <2 years, n = 13
(F) 2-4 years, n = 19
(G) 4-6 years, n = 18 and
(H) >6 years n = 25
AU children received an individual mixture of regulär and NPH
porcine insulin (Nordisk) and the daily insulin feqüitement was
0.81 ± 0.27 (x ± s, lU/kg body weight).
According to the HbAic values good control was achieved in 2.8
children and satisfactory control in 29 juvenile djabetics, while
control was poor in 18 children.
Control values of the insulin binding to erythrocytes were mea-
sured in 33 metabolically healthy children ($ 15,18 d) between l
and 15 years of age (8.06 ± 5.2, ± s).
The body height of all chijdren was between the 25th and 75th
percentile; all children had normal weight corresponcjing to their
heights. Liver diseases and renal djseases äs well äs disturbances
of blood formation had been excluded by preliminary exafnina-
tions.
Insulin binding studies
12 hours after the last insulin injection and the last food ingestion,
approximately 10 ml of heparinized whole blood were-taken by
venipuncture.
Insulin binding was perfoffned according to the procedure of
Gambhir et äl. (13) with slight rhodifications (14). Isolated ery-
throcytes (3.5-4.5 x 1012/1) were incubated with porcine [125I]in-
sulin (0.05 nfnol/1) and ünlabeled pork insulin (0.09—174 nmol/1)
at 15°C for 3 hours.
t*
Calculation procedures
For parameter extraction a nonlinear regression procedure was
applied (15). The insulin receptor affinity (Ka), the insulin recep-
tor concentration (X0), and the nonspecific binding (U) were iter-
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atively determined for the one-class binding modcl via minimiza-
tion of the sum of the squares of error with the aid of a HP 98 35
A Computer.
For statistical analyses parametric procedures (t-tcst for unpaired
data) were applied in cases of normal distribution of the data;
otherwise nonparametric procedures (Mann-Whitney- and Wil-
coxon lest, respectively) were employed.
than those obtained in the healthy control group. In
the diabetics older than 10 years, differences of only
107% for the insulin receptor affinity (18.5 versus
8.9 x 10* 1/mol) and 21% for the insulin receptor
concentration (0.048 versus 0.061 nmol/1) were de-
tected (figs. l, 2; tabs. l, 2).
Analytical procedures
C-peptide in serum and daily C-peptide excretion in urine were
determined radioimmunologically (16). HbA]C values in blood
were measured according to I.e. (17).
Results
The juvenile diabetics showed a higher insulin recep-
tor affinity (p < 0.001) and a lower insulin receptor
concentration (p < 0.001) compared with healthy
children of the same age.
The most marked differences were observed in the
group of children under 10 years of age. With a
receptor affinity of 28.9 compared with 8.7 x 108
1/mol and a receptor concentration of 0.028 com-
pared with 0.067 nmol/1, the respective values in the
diabetic children were 232% higher and 58% lower
Tab. 1. Insulin receptor affinity (Ka ± s*,) and concentration
(xo ± Sx,,) in healthy and diabetic children subdivided ac-
cording to their age.
Affinity Ka Concentration Xo
(108I/mol) (nmol/1)
8.7 ± 2.0 0.067 ±0.031
8.9 ± 1.6 0.061 ±0.014
Controls < 10 years
(group A; n ==20)
Controls > 10 years
(group B; n = 13)
Diabetic children < 10 years 28.9 ± 11.7 0.028 ± 0.016
(group C; n = 12)
Diabetic children > 10 years 18.5 + 10.4 0.048 + 0.028
(group D; n = 63)
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Fig. 1. Specific insulin binding to human erythrocytes (4 x
1012/1) in healthy (O) and diabetic children (E) younger
than^ ten years.
Means of [125I]insulin binding (B/T) in dependence on the
total insulin concentrations (nmol/1), corrected by iterated
unspecific binding.
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Fig. 2. Specific insulin binding to human erythrocytes (4 x
1012/1) in healthy (Ö) and diabetic children (D) older than
ten years.
Means of [125I]insulin binding (B/T) in dependence on the
total insulin concentrations (nmol/l), corrected by iterated
unspecific binding.
Tab. 2. Statistical compafison of insulin receptor affinities (Ka) and concentrations (X0) in healthy and diabetic children subdivided
according to their age.
Groups Diabetic children > 10 years
(group D; n = 63)
Diabetic children < 10 years
(group C; n = 12)
Controls > 10 years
(group B; n = 13)
Controls < 10 years
(group A; n = 20)
Controls > 10 years
(groupB^n^ 13)
Diabetic children < 10 years
(group C; n = 12)
Ka
Xo
Ka
Xo
Ka
Xo
p < 0.001
p < 0.001
p < 0.001
p<0.001
p < 0.005
p < 0.025
p < 0.001
p < 0.001
p < 0.001
p < 0.001
n. s.
n. s.
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An age-dependent change in the insulin receptor af-
finity and/or the insulin receptor concentration
could not be shown in the healthy children (tabs. l,
2). In contrast, the older diabetic children (group C
äs compared to group D) showed a significantly
higher insulin receptor concentration (0.048 versus
0.028 nmol/1; p < 0.025) and also a significantly
lower insulin receptor affinity (18.5 versus 28.9 x
l O8 1/mol; p < 0.005) (tabs. l, 2).
In addition, the daily insulin requirement was higher
in older diabetics (0.84 äs compared to 0.60 lU/kg
body weight, p < 0.005), the metabolic control was
deteriorated (HbAic values 0.091 versus 0.073 frac-
tion of total haemoglobin, p < 0.01), and - äs ex-
pected - the duration of diabetes was longer (p <
0.001). No statistically significant differences in the
residual function of the beta cells (fasting C-peptide
value and 24-hour excretion of C-peptide in the
urine) could be shown between the two groups of
diabetic children (tab. 3).
• \
Within the first 2 years of the disease the receptor
affinity feil significantly (p < 0.005) from 30.0 to
19.6 x 1081/mol, and the receptor concentration also
rose significantly (p < 0.01) from 0.024 to 0.044
nmol/1 (fig. 3; tabs. 4, 5). In the following years of
the disease no further changes could be detected.
Significant changes in the insulin requirement (p <
0.005) äs well äs in the C-peptide excretion in the
24-hour urine (p < 0.001) were also limited to the
first 2 years of the disease (tab. 6). The HbAic values
and the fasting C-peptide values, however, were ex-
cluded (tab. 6).
10
lnmol/l]
Fig. 3. Specific insulin binding to human erythrocytes (4 x
1012/1) in four groups of diabetic children, subdivided ac-
cording lo the duration of the disease: (O) <2 years, (A)
2-4 years, (D) 4-6 years (O) >6 years.
Means of [I25l]insulin binding (B/T) in dependence on the
total insulin concentrations (nmol/1), corrected by iterat-
ed unspecific binding.
Tab. 3. Duration of diabetes, daily insulin requirement, C-pep-
tide serum levels, daily urinary C-peptide excretion and
HbAic-values in diabetic children subdivided according
to their age ( ± s).
Diabetic
children
< 10 years
(group C)
Diabetic children
> 10 years
{group D)
n 12 63
Duration of diabetes 1.85 ± 1.70 6.38 ± 3.79***)
(years)
Daily insulin requirement 0.60 ±0.30 0,84 ±0.24**)
(lU/kg body weight)
C-peptide serum levels
(nmol/1)
Daily urinary C-peptide
excretion
(nmol)
HbAu-values
(fraction of total
haemoglobin)
0.24 ±0.06 0.24 ±0.09
2.06 ±2.21 1.43 ±2.53
0.073 ± 0.014 0.091 ±0.020*)
***) p < 0.001 *) p < 0.005 *) p < 0.01
Tab. 4. Insulin receptor affinity (Ka ± SKa) and concentrations
(Xo ± Sxj in four groups of diabetic children subdivided
according to the durätion of the disease.
Affinity Ka Concentration Xo
(10M/mol) (nmoi/1)
Duration of diabetes <2 years 30.0 ± 8.6 0.024 ± 0*007
(group E; n = 13)
Duration of diabetes 2-4 years 19.6 ± 9.7 0.044 ± 0.026
(group F; n = 19)
Duration of diabetes 4-6 years 18.3 ± 9.8 0,044 ± 0.021
(group G; n = 18)
Duration of diabetes >6 years 17.7 ±11.5 0.052 ± 0.031
(group H; n = 25)
Discussion
The clinical manifestation of type-I diabetes is the
consequence of an absolute insulin deficiency pre-
ceded by a period of a relative insulin deficiency of
varying duration, with an increäsing loss of the endo-
genous insulin secretion (18).
The receptor affinity Ka in the 12 diabetic children
with short düration of diabetes (group E) exceedod
the values obtained in healthy vohinteefs by an aver-
age of 240%, while the receptor concentration (X0)
was 54% lower than that of healthy voiunteers. The
more pronounced the differences the shorter was the
duration of diabetes. .'
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Tab. 5. Statistical comparison of insulin rcceptor affinities (Ka) and concentrations (X„) in four groups of diabetic childrcn subdivided
according to the duration of thc disease.
Groups Duration ofdiabetcs
> 6 years
(group H; n-25)
Duration of diabctes
4—6 years
(group G; n = 18)
Duration ofdiabetcs
2—4 years
(groupF;n = 19)
Duration of diabetes
< 2 years
(groupE;n « 13)
Duration of diabetes
2-4 years
(group F; n « 19)
Duration of diabetes
4— 6 years
(group G; n = 18)
K,
Xo
Ka
Xo
Ka
Xo
p < 0.005
p<0.0l
n. s.
n. s.
n. s.
n. s.
p < 0.005
p<0.01
n. s.
n. s.
p < 0.005
p < 0.01
Tab. 6. Daily insulin rcquiremenu C-peptidc serum levels, daily urinary C-peptidc excretion and HbAjc-vaIues in four groups of diabetic
children subdivided according to the duration of the discasc ( ± s).
Duration of diabetes mellitus
< 2 years 2-4 years 4—6 years > 6 years
(group E; n = 13) (group F; n = 19) (group G; n = 18) (group H; n = 25)
Daily insulin requirement 0.52 ±0.34 0.84 ±0.26** 0.88 ±0.21
(lU/kgbodyweight
C-peptide serum levcls 0.33 ±0.12 0.21 ±0.07 0.23 ±0.06
(nmol/l)
Daily urinary C-peptide excretion 4.93 ±3.17 1.13 ±1.91*** 1.51 ±2.48
(nmol)
HbA,c-values 0.075 ± 0.022 0.089 ± 0.02 1 0.088 ± 0.021
(fraction of total haemoglobin)
0.89 ±0.19
0.22 ±0.06
0.31 ±0.19
0.093 ±0.01 9
p < 0.001 ** < 0.005
The child with the shortest duration of the disease
(< l month) showed an insulin receptor affinity Ka
(43.5 -108 1/mol) of 390% above that in healthy
children and a receptor concentration (Xo) (0.015
nmol/l) of 76% below that in healthy children.
It seems obvioüs that, in the preclinical phase of
type-J diabetes, the stepwise decrease of the endo-
genous insulin secretion induces a counterregulatory
increase in the insulin receptor affinity and a de^
crease in the insulin receptor concentration; and this
process is reversed by the administration of exogen-
ous insulin.
After oiiset of the disease a partial remission over a
period of months or even years may be observed in
raany juvenile diabetics, which is characterized by
good metabolic control, low insulin requirement
(<0.50 JU/kg body weight), and a residual insulin
secretion (16, 19). The partial remission turns into
the phase of total diabetes chäräcterized by complete
loss of the residual function of the beta cells and an
iiicreased insulin requirement (>0.50 lU/kg body
weight) (16).
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It is only during the phase of partial remission that
exogenous insulin and endogenous insulin compete
at the receptor site. Depending on the duration of
the disease, the portion of endogenous insulin de-
creases more and more; in the phase of total diab.etes
the insulin effect at the receptor site is completely
exerted by exogenous insulin.
10 of the 13 diabetic children with short duration of
diabetes still were in the phase of partial remission.
After duration of the disease over a period of more
than 4 years (groups G and H) total diabetes was
diagnosed in all children. In group F (diabetes dura-
tion of 2—4 years) only one out of 20 children met
the criteria of partial remission.
Since only groups E and F showed changes in the
binding parameters depending on the duration of di-
abetes (i.e., within the first two years of the disease),
the change is obviously induced by the successive
supplementation of endogenous insulin by exogen-
ous insulin.
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This is proved by the fact that in the phase of total
diabetes (groups F to H) no alterations of the bind-
ing parameters were observed, and that juvenile dia-
betics showed an increase in receptor affinity of
106% and a decrease in the receptor conceriträtion
of 57%, in the phase of total diabetes after changing
of treatment to biosynthetic human insulin (20).
Schlüter et al. (21) even described an increase in the
receptor affinity of 200% in adult type-I diabetics 9
months after changing of treatment to biosynthetic
human insulin.
Firially, the apparent age-dependent differences ob-
served in the binding parameters in diabetic children
can be explained äs follows. In the group of juvenile
diabetics under 10 years of age (group C) 6 out of 12
children were in the phase of partial remission,
whereas in the group of oldef diabetic children
(group D) only 5 of 63 met the criteria of partial
remission with low insulin requirement and residual
insulin secretion.
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